These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 26345890

  • 1. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
    Dong L, Chen CY, Ning B, Xu DL, Gao JH, Wang LL, Yan SY, Cheng S.
    Genet Mol Res; 2015 Aug 14; 14(3):9571-84. PubMed ID: 26345890
    [Abstract] [Full Text] [Related]

  • 2. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T, Diamond TH, Manoharan A, Ramakrishna R.
    Integr Cancer Ther; 2016 Jun 14; 15(2):183-9. PubMed ID: 27154182
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 14; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 4. Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.
    Bogun L, Koch A, Scherer B, Fenk R, Maus U, Bormann F, Köhrer K, Petzsch P, Wachtmeister T, Zukovs R, Dietrich S, Haas R, Schroeder T, Jäger P, Geyh S.
    Blood Adv; 2024 May 28; 8(10):2575-2588. PubMed ID: 38241490
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
    Scudla V, Ordeltova M, Bacovsky J, Vytrasova M, Sumna E, Martinek A, Horak P.
    Neoplasma; 2003 May 28; 50(5):363-71. PubMed ID: 14628090
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
    Hillengass J, Moehler T, Hundemer M.
    Recent Results Cancer Res; 2011 May 28; 183():113-31. PubMed ID: 21509683
    [Abstract] [Full Text] [Related]

  • 9. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Lacy MQ, Donovan KA, Heimbach JK, Ahmann GJ, Lust JA.
    Blood; 1999 Jan 01; 93(1):300-5. PubMed ID: 9864174
    [Abstract] [Full Text] [Related]

  • 10. 3D osteocyte lacunar morphometry of human bone biopsies with high resolution microCT: From monoclonal gammopathy to newly diagnosed multiple myeloma.
    Moreno-Jiménez I, Heinig S, Heras U, Maichl DS, Strifler S, Leich E, Blouin S, Fratzl P, Fratzl-Zelman N, Jundt F, Cipitria A.
    Bone; 2024 Dec 01; 189():117236. PubMed ID: 39151745
    [Abstract] [Full Text] [Related]

  • 11. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF.
    Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290
    [Abstract] [Full Text] [Related]

  • 12. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.
    Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE.
    Blood; 1996 Jul 01; 88(1):289-96. PubMed ID: 8704185
    [Abstract] [Full Text] [Related]

  • 13. Host-related immunodeficiency in the development of multiple myeloma.
    Dosani T, Mailankody S, Korde N, Manasanch E, Bhutani M, Tageja N, Roschewski M, Kwok M, Kazandjian D, Costello R, Burton D, Zhang Y, Liewehr D, Steinberg SM, Maric I, Landgren O.
    Leuk Lymphoma; 2018 May 01; 59(5):1127-1132. PubMed ID: 28792255
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW, Mutis T, Poddighe PJ, Lokhorst HM, Zweegman S.
    Int J Lab Hematol; 2016 May 01; 38 Suppl 1():110-22. PubMed ID: 27161311
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
    Korde N, Kristinsson SY, Landgren O.
    Blood; 2011 May 26; 117(21):5573-81. PubMed ID: 21441462
    [Abstract] [Full Text] [Related]

  • 16. The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
    Emery A, Moore S, Crowe J, Murray J, Peacock O, Thompson D, Betts F, Rapps S, Ross L, Rothschild-Rodriguez D, Arana Echarri A, Davies R, Lewis R, Augustine DX, Whiteway A, Afzal Z, Heaney J, Drayson MT, Turner JE, Campbell JP.
    BMC Cancer; 2024 Feb 05; 24(1):174. PubMed ID: 38317104
    [Abstract] [Full Text] [Related]

  • 17. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G.
    Leukemia; 2020 Dec 05; 34(12):3111-3125. PubMed ID: 33046818
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach.
    Khalili P, Maddah R, Maleknia M, Shateri Amiri B, Forouzani F, Hasanvand A, Rezaeeyan H.
    Mol Biotechnol; 2023 Aug 05; 65(8):1275-1286. PubMed ID: 36504354
    [Abstract] [Full Text] [Related]

  • 19. MGUS to myeloma: a mysterious gammopathy of underexplored significance.
    Dhodapkar MV.
    Blood; 2016 Dec 08; 128(23):2599-2606. PubMed ID: 27737890
    [Abstract] [Full Text] [Related]

  • 20. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P, Peran I, Skrtić A, Ajduković R, Kristo DR, Dominis M.
    Pathol Int; 2009 May 08; 59(5):354-8. PubMed ID: 19432679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.